Count | |
| 2 | |
Hematoporphyrin Derivative/administration & dosage/therapeutic use | 1 |
| 9 | |
| 2 | |
| 1 | |
| 5 | |
| 1 | |
Vinblastine/administration & dosage/adverse effects/*analogs & derivative | 1 |
Vidarabine/administration & dosage/*adverse effects/*analogs & derivative | 1 |
| 2 | |
| 6 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 7 | |
| 2 | |
| 10 | |
| 10 | |
| 1 | |
| 1 | |
| 5 | |
| 6 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 14 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 2 | |
| 8 | |
| 16 | |
| 2 | |
| 4 | |
| 1 | |
| 3 | |
| 1 | |
| 4 | |
| 7 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 10 | |
| 1 | |
| 8 | |
| 2 | |
| 1 | |
| 17 | |
| 1 | |
| 2 | |
| 27 | |
| 6 | |
| 8 | |
| 10 | |
| 2 | |
| 3 | |
| 1 | |
| 4 | |
| 12 | |
| 13 | |
| 7 | |
| 2 | |
| 1 | |
| 13 | |
| 4 | |
| 3 | |
| 7 | |
| 4 | |
| 2 | |
| 8 | |
| 1 | |
| 1 | |
| 3 | |
| 2 | |
| 7 | |
| 1 | |
| 1 | |
| 1 | |
| 5 | |
| 2 | |
| 6 | |
| 2 | |